Patients with a nonrejection-related diagnosis according to the 2019 Banff classification who were reclassified as MVI, ...

The following is a summary of “Efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or combination therapy versus platinum-based chemotherapy as a first-line treatment of advanced urothelial cancer ...

New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...

In this randomized controlled trial, abelacimab led to significantly lower rates of major or clinically relevant nonmajor ...

In this randomized trial, intraosseous-first vascular access did not result in higher 30-day survival than intravenous-first ...

The number of mpox cases in Africa increased leading up to the first mpox declaration of a Public Health Emergency of ...

In this randomized controlled trial, a transcatheter tricuspid-valve replacement provided a mortality benefit compared to ...

In this randomized controlled trial, among patients with persistent chylomicronemia, it was found that plozasiran more ...

In a groundbreaking clinical trial, immunotherapy alone eliminated rectal cancer in all 14 participants. This study, the ...

Foresight Diagnostics, which provides ultra-sensitive minimal residual disease (MRD) detection technology, today announced the launch of the PRECISE-HL clinical trial with the University of Washington ...

Vutrisiran treatment reduced the risk of death and recurrent cardiovascular events compared to placebo in patients with ...

In this randomized, placebo-controlled replicate trial, depemokimab decreased the annual rate of exacerbations among patients ...